TagerI, SpeizerFE. Role of infection in chronic bronchitis. N Engl J Med1975;292:563–571.
2.
RichardsonPS, PhippsRJ. The anatomy, physiology, pharmacology and pathology of tracheobronchial mucus secretion and the use of expectorant drugs in human disease. Pharmacol Ther B1978;3:441–479.
3.
NadelJA. Regulation of fluid and mucous secretion in airways. J Allergy Clin Immunol1981;67:417–420.
4.
BoydEM. A review of studies on the pharmacology of expectorants and inhalants. Int J Clin Pharmacol1970;3:55–60.
5.
Symposium. Mucolytics and oral acetylcysteine. Eur J Respir Dis1980;61(Suppl III).
MartinR, LittM, MarriottC.The effect of mucolytic agents on the rheologic and transport properties of canine tracheal mucus. Am Rev Respir Dis1980;121:495–500.
8.
ZimentI.What to expect from expectorants. JAMA1976;236:193–194.
9.
PuchelleE, SadoulP.The effect of mucolytic agents on the rheologic and transport properties of canine tracheal mucus. Am Rev Respir Dis1980;122:808–809.
